SBRA · XBRL financial data

Sabra Health Care REIT financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SBRA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue	163*	167	176	178	182*	184	189	190	212*	222	236	250
Revenue from contracts with customers	61*	66	68	74	77*	77	79	92	108*	117	129	143
General and administrative	17*	12	13	12	13*	13	13	13	16*	15	17	16
Other operating income (expense)	0*	1	0	0	2*	0	15	(1)	0*	(0)	(3)	(0)
Interest expense	28*	28	29	29	28*	27	28	29	29*	28	30	29
Other income (expense)	(1)*	1	2	(6)	8*	—	25	(6)	(9)*	—	35	(8)
Income tax expense (benefit)	0*	0	0	(0)	0*	0	0	0	0*	1	1	0
Net income (loss)	17*	26	24	30	47*	40	66	23	27*	41	(25)	29
Earnings per share, basic USD per share	0.07*	0.11	0.10	0.13	0.20*	0.17	0.28	0.09	0.11*	0.16	(0.10)	0.11
Earnings per share, diluted USD per share	0.07*	0.11	0.10	0.13	0.19*	0.17	0.27	0.09	0.11*	0.16	(0.10)	0.11
Weighted average shares, basic millions of shares	231*	231	232	234	237*	238	238	240	249*	252	252	256
Weighted average shares, diluted millions of shares	236*	233	234	237	240*	240	241	244	253*	256	252	260

Fiscal quarters (SBRA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	41	60	36	63	60	23	95	201	72	117	232	36
Right-of-use asset	12	11	11	7	7	7	7	7	7	6	6	6
Total assets	5,386	5,374	5,351	5,366	5,304	5,233	5,328	5,565	5,493	5,591	5,513	5,430
Total liabilities	2,584	2,607	2,589	2,621	2,562	2,531	2,617	2,738	2,670	2,803	2,760	2,589
Total stockholders' equity	2,803	2,767	2,762	2,745	2,741	2,702	2,711	2,825	2,822	2,786	2,751	2,840
Total liabilities and equity	5,386	5,374	5,351	5,366	5,304	5,233	5,328	5,565	5,493	5,591	5,513	5,430
Common shares outstanding (cover page) millions of shares	231	231	234	237	238	238	240	249	252	252	255	262

Fiscal quarters (SBRA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	17*	26	24	30	47*	40	66	23	27*	41	(25)	29
Stock-based compensation	2*	3	1*	3*	3*	3	3*	3*	3*	3	4*	4*
Depreciation and amortization	43*	43	42	43	42*	43	44	49	51*	53	56	65
Net cash from operating activities	79*	53	80*	98*	80*	80	81*	100*	87*	98	86*	129*
Net cash from investing activities	(62)*	(13)	(57)*	(57)*	19*	(16)	(45)*	(200)*	(117)*	(105)	87*	(172)*
Dividends paid	69*	69	69*	70*	71*	71	71*	72*	75*	76	76*	77*
Net cash from financing activities	(9)*	(20)	(46)*	(14)*	(101)*	(101)	37*	206*	(101)*	52	(57)*	(152)*

SIC 6798 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 6798 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Sabra Health Care REIT	36	143	129*	262.0M	Q3 FY26 10-QSep 30, 2026
Phillips Edison & Company	8.9	3.5	85*	129.0M	Q3 FY26 10-QSep 30, 2026
EPR Properties	52	204	169*	76.6M	Q3 FY26 10-QSep 30, 2026
Independence Realty Trust	16	172	81*	235.9M	Q3 FY26 10-QSep 30, 2026
Ares Real Estate Income Trust	41	151	189*	not reported	Q2 FY26 10-QJun 30, 2026
Americold Realty Trust	40	663	100*	285.5M	Q2 FY26 10-QJun 30, 2026
Macerich	227	250	67*	283.6M	Q2 FY26 10-QJun 30, 2026
Kilroy Realty	94	4.9	not reported	116.3M	Q3 FY26 10-QSep 30, 2026
Kite Realty Group Trust	33	190	104*	198.0M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.